ARMADA ACQUISITION CORP. II (XRPN)
Evernorth Advances Business Combination with Public S-4 Filing
Evernorth Advances Business Combination with Public S-4 Filing
SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS
Other Report or Announcement
Other Report or Announcement
Other Report or Announcement
Other Report or Announcement
Other Report or Announcement
Other Report or Announcement
Other Report or Announcement
Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026